Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07483307
What this trial is testing

The Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 176
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Not applicableNot Yet RecruitingNCT06541171
What this trial is testing

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 220
Testing effectiveness (Phase 2)Study completedNCT01636934
What this trial is testing

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Not applicableUnknownNCT03150121
What this trial is testing

Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

Who this might be right for
Ovarian CancerOvarian CarcinomaFallopian Tube Cancer+2 more
Sheba Medical Center 500
Not applicableUnknownNCT02736916
What this trial is testing

HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell Lung
General Hospital of Ningxia Medical University 3
Testing effectiveness (Phase 2)UnknownNCT05130684
What this trial is testing

Neo-NTP-CRT for Locally Advanced ESCC

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 43
Testing effectiveness (Phase 2)Study completedNCT00459875
What this trial is testing

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05132075
What this trial is testing

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 95
Not applicableLooking for participantsNCT06648057
What this trial is testing

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
CHA University 100
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Testing effectiveness (Phase 2)Study completedNCT03357757
What this trial is testing

Avelumab With Valproic Acid in Virus-associated Cancer

Who this might be right for
Cancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more
AHS Cancer Control Alberta 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)UnknownNCT00055965
What this trial is testing

Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust 400
Large-scale testing (Phase 3)Study completedNCT01228565
What this trial is testing

Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®

Who this might be right for
Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 76
Not applicableActive Not RecruitingNCT02863107
What this trial is testing

Young-Onset Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaColorectal CarcinomaRectal Adenocarcinoma
M.D. Anderson Cancer Center 818
Not applicableUnknownNCT04810936
What this trial is testing

Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy

Who this might be right for
MalnutritionNasopharyngeal Carcinoma
Guangdong Provincial People's Hospital 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388836
What this trial is testing

Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Fujian Cancer Hospital 198
Next Page